Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Ciphergen Biosystems (NasdaqNM:CIPH)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
6611 Dumbarton Circle
Fremont, CA 94555
Phone: (510) 505-2100
Fax: (510) 505-2101
Email: info@ciphergen.com
Employees (last reported count): 114
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Technology
 ·Industry: Scientific & Technical Instr.
Company Websites
 ·Home Page
 ·Investor Relations
 ·Products & Services
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 54%
·Over the last 6 months:
 · 2 insider sells; 234.0K shares
  (1.6% of insider shares)
·Institutional: 34% (74% of float)
(71 institutions)
·Net Inst. Buying: 3.09M shares (+25.29%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Ciphergen Biosystems, Inc. develops, manufactures and markets its ProteinChip System using patented Surface Enhanced Laser Desorption/Ionization technology. The ProteinChip System enables protein discovery, characterization and assay development to provide researchers with a better understanding of biological functions at the protein level. Protein characterization is the determination of the detailed identity of a protein, including its sequence as predicted by the corresponding gene and any chemical modifications introduced after the protein is produced. Assay development is the simplification and optimization of a set of procedures to develop a method for quantifying a specific protein. The Company has commercially launched its ProteinChip System, Series PBS II, which consists of disposable ProteinChip Arrays, a ProteinChip Reader and its proprietary ProteinChip Software.
More from Market Guide: Expanded Business Description

Financial Summary
Ciphergen Biosystems develops, manufactures and markets the ProteinChip System, enabling protein discovery, characterization and assay development to provide researchers with a better understanding of biological functions at the protein level. For the six months ended 6/30/01, revenue rose 74% to $6.3 million. Net loss applicable to Common decreased 68% to $11.8 million. Results reflect increased unit sales of ProteinChip systems, partially offset by higher R&D costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Pay

John Young, 68
Chairman
--  
William Rich, Ph.D., 56
Pres, CEO, Director
$442K
David DeNola, 51
VP-Operations
202K
Martin Verhoef, 41
VP of Sales and Marketing
182K
Christopher Pohl, 49
VP-R&D
183K
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc..
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:CIPHAs of 31-Aug-2001
Price and Volume
52-Week Low
on 29-Mar-2001
$3.75 
Recent Price$4.18 
52-Week High
on 2-Oct-2000
$39.438
Daily Volume (3-month avg)62.8K
Daily Volume (10-day avg)33.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y]
26-Week Change-29.6%
26-Week Change
relative to S&P500
-23.4%
Share-Related Items
Market Capitalization$112.7M
Shares Outstanding27.0M
Float12.4M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$3.87 
Earnings (ttm)-$1.52 
Earnings (mrq)-$0.22 
Sales (ttm)$0.54 
Cash (mrq)$3.36 
Valuation Ratios
Price/Book (mrq)1.08 
Price/EarningsN/A 
Price/Sales (ttm)7.71 
Income Statements
Sales (ttm)$11.6M
EBITDA (ttm)-$27.0M
Income available to common (ttm)-$22.9M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-23.45%
Return on Equity (ttm)-28.38%
Financial Strength
Current Ratio (mrq)16.02 
Debt/Equity (mrq)0.01 
Total Cash (mrq)$90.6M
Short Interest
As of 8-Aug-2001
Shares Short116.0K
Percent of Float0.9%
Shares Short
(Prior Month)
182.0K
Short Ratio3.05 
Daily Volume38.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.